AF
XBI icon

Alerus Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Alerus Financial’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9K Hold
140
– – ﹤0.01% 353
2025
Q4 		$17.1K Hold
140
– – ﹤0.01% 310
2025
Q3 		$14K Sell
140
-70
-33% -$6.3K ﹤0.01% 347
2025
Q2 		$17.4K Buy
+210
New +$16.8K ﹤0.01% 317
2024
Q4 		– Sell
-34,314
Closed -$3.39M – 168
2024
Q3 		$3.39M Sell
34,314
-346
-1% -$34K 0.25% 81
2024
Q2 		$3.21M Sell
34,660
-137
-0.4% -$12.3K 0.24% 77
2024
Q1 		$3.3M Sell
34,797
-56
-0.2% -$5.2K 0.25% 83
2023
Q4 		$3.11M Sell
34,853
-19,802
-36% -$1.47M 0.25% 82
2023
Q3 		$3.99M Buy
54,655
+349
+0.6% +$27.9K 0.35% 71
2023
Q2 		$4.52M Buy
54,306
+954
+2% +$79.8K 0.38% 74
2023
Q1 		$4.07M Sell
53,352
-19,419
-27% -$1.61M 0.36% 77
2022
Q4 		$6.04M Buy
72,771
+2,600
+4% +$210K 0.55% 53
2022
Q3 		$5.57M Buy
70,171
+31,937
+84% +$2.69M 0.55% 46
2022
Q2 		$2.84M Buy
+38,234
New +$2.87M 0.26% 87
2022
Q1 		– Sell
-2,378
Closed -$266K – 191
2021
Q4 		$266K Sell
2,378
-27,009
-92% -$3.26M 0.02% 169
2021
Q3 		$3.69M Buy
29,387
+1,571
+6% +$202K 0.34% 77
2021
Q2 		$3.77M Buy
27,816
+272
+1% +$35.8K 0.38% 68
2021
Q1 		$3.74M Buy
27,544
+6,487
+31% +$971K 0.39% 71
2020
Q4 		$2.96M Buy
21,057
+833
+4% +$107K 0.3% 86
2020
Q3 		$2.25M Buy
20,224
+9,520
+89% +$1.07M 0.25% 95
2020
Q2 		$1.2M Buy
10,704
+729
+7% +$71.8K 0.14% 109
2020
Q1 		$772K Buy
9,975
+91
+0.9% +$8.06K 0.11% 111
2019
Q4 		$940K Buy
9,884
+120
+1% +$10.4K 0.11% 108
2019
Q3 		$745K Buy
+9,764
New +$811K 0.1% 110
2019
Q1 		– Sell
-18,138
Closed -$1.3M – 154
2018
Q4 		$1.3M Buy
+18,138
New +$1.46M 0.2% 94

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alerus Financial's XBI Position: Q1 2026 in Review

Alerus Financial held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 140 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #353.

Alerus Financial first reported a position in XBI in Q4 2018 and has held it in 25 quarters since. The position peaked at $6.04M in Q4 2022. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Alerus Financial held 140 shares of State Street SPDR S&P Biotech ETF worth $17.9K as of Q1 2026.
  • Alerus Financial left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Alerus Financial's portfolio in Q1 2026, its #353 holding.
  • Alerus Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 25 quarters since.
  • Alerus Financial's State Street SPDR S&P Biotech ETF position peaked at $6.04M in Q4 2022.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.